<DOC>
	<DOCNO>NCT02208089</DOCNO>
	<brief_summary>Young patient keratoconus face two problem : disease progression corneal shape irregularity lead poor vision even spectacle . Corneal collagen cross-linking ( CXL ) new treatment design halt disease progression keratoconus . The aim stiffen cornea thereby prevent shape deterioration . Topography wavefront guide transepithelial photorefractive keratectomy ( transPRK ) use excimer laser ( laser use correct sight 'laser eye surgery ' ) reduce corneal shape irregularity early stage keratoconus , reduce dependence contact lenses . In transPRK , corneal skin layer remove well control , touch procedure , prepare cornea CXL . Performing treatment simultaneously ( combine procedure one operation ) may offer several advantage perform CXL first wait corneal shape stabilise perform transPRK . In particular , visual rehabilitation may faster . This study aim evaluate visual recovery simultaneous CXL transPRK progressive early stage keratoconus . Visual recovery patient compare result similar group patient early stage keratoconus already treat CXL alone .</brief_summary>
	<brief_title>Simultaneous TransPRK Corneal Collagen Cross-Linking</brief_title>
	<detailed_description>Features distinguish trial previous trial combine photorefractive keratectomy ( PRK ) corneal collagen cross-linking ( CXL ) : rapid , pulsed light , CXL protocol ; treatment program algorithm PRK design target high order aberration compensatory additional laser corneal tissue removal . Excimer laser treatment perform Schwind Amaris 750S laser ( www.eye-tech-solutions.com ) . Unique feature system utilised include : - Pre-programmed transepithelial ablation - laser removal minimum area corneal epithelium require PRK promote rapid recovery conventional method ( 20 % alcohol application manual epithelial removal ) . An 8mm diameter ablation zone apply throughout . - Enhanced algorithms minimal laser tissue removal - trial , investigator target high order aberration ( coma particular ) aim improve spectacle correct visual acuity without regard predict spherocylindrical outcome . Unlike current excimer laser platform , Schwind Amaris treatment program software allow treatment irregular astigmatism without additional compensatory laser tissue removal correct spherocylindrical change induce treatment high order aberration . Higher order aberration also treat selectively . The investigator use algorithm step target aberration ( 6th order Zernike polynomial ) value great 2 standard deviation population mean normative data . These treatment planning step allow laser create large diameter treatment minimal treatment depth . Laser epithelial removal alone ( transPTK depth 55µm ) remove maximum 65µm tissue corneal periphery . For patient 390µm thin point , transPTK therefore leave 325µm residual stromal thickness prior CXL . This line recommendation minimum stromal thickness epithelial removal CXL protocol use . Limited stromal reshape achieve simple embodiment transPRK keratoconus take advantage mask effect corneal epithelium , tend thin cone apex . Where thin point great 390µm , reduction corneal shape irregularity produce add either wavefront topography guide additional stromal ablation use custom program Schwind Amaris laser . Ocular wavefront ( aberrometry ) guide smooth use patient 5.5mm large pupil scan consistent scan sequence ( 3 scan within 0.5 dioptre ( D ) spherical equivalent refraction ) . Corneal wavefront ( topography ) guide smooth use patient ocular wavefront scan meet criterion . In case , minimum corneal stromal thickness prior CXL 325µm preserve . Immediately PRK , corneal collagen cross-linking perform use follow protocol Riboflavin soak : 10 minute total soak time ; application 0.1 % riboflavin preparation ( VibeX Rapid - www.avedro.com ) 2 minute gentle balance salt solution irrigation remove excess riboflavin prior UV light exposure . UV light exposure : Total treatment time 8 minute ( 370nm wavelength ; 30mW/cm2 irradiance ; 4 minute total UV exposure time , pulse 1.5 second 1.5 second ; Avedro KXL I light source ) Mitomycin C use . A bandage contact lens applied end treatment standard post photorefractive keratectomy topical systemic drug treatment regimen use every case initial clinical review 1 week surgery .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<criteria>Patients progressive stage II III keratoconus CDVA &lt; 0.00 logMAR subjective problem spectacle correct visual quality ( ghost image light scatter symptom ) Active ocular surface disease Minimum corneal thickness &lt; 390µm ( leave 325µm residual stromal thickness transPTK line minimum thickness recommendation study CXL protocol ) Vulnerable group ( patient whose capacity give informed consent participate trial may impair )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Keratoconus</keyword>
	<keyword>Corneal collagen cross-linking</keyword>
	<keyword>Photorefractive keratectomy</keyword>
</DOC>